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Background: Microarray analysis has been used as the first-tier genetic testing to detect chromosomal imbalances
and copy number variants (CNVs) for pediatric patients with intellectual and developmental disabilities (ID/DD). To
further investigate the candidate genes and underlying dosage-sensitive mechanisms related to ID, cytogenomic
mapping of critical regions and bioinformatic mining of candidate brain-expressed genes (BEGs) and their functional
interactions were performed. Critical regions of chromosomal imbalances and pathogenic CNVs were mapped by
subtracting known benign CNVs from the Databases of Genomic Variants (DGV) and extracting smallest overlap
regions with cases from DatabasE of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources
(DECIPHER). BEGs from these critical regions were revealed by functional annotation using Database for Annotation,
Visualization, and Integrated Discovery (DAVID) and by tissue expression pattern from Uniprot. Cross-region
interrelations and functional networks of the BEGs were analyzed using Gene Relationships Across Implicated
Loci (GRAIL) and Ingenuity Pathway Analysis (IPA).
Results: Of the 1,354 patients analyzed by oligonucleotide array comparative genomic hybridization (aCGH),
pathogenic abnormalities were detected in 176 patients including genomic disorders in 66 patients (37.5%),
subtelomeric rearrangements in 45 patients (25.6%), interstitial imbalances in 33 patients (18.8%), chromosomal
structural rearrangements in 17 patients (9.7%) and aneuploidies in 15 patients (8.5%). Subtractive and extractive
mapping defined 82 disjointed critical regions from the detected abnormalities. A total of 461 BEGs was generated
from 73 disjointed critical regions. Enrichment of central nervous system specific genes in these regions was noted.
The number of BEGs increased with the size of the regions. A list of 108 candidate BEGs with significant cross
region interrelation was identified by GRAIL and five significant gene networks involving cell cycle, cell-to-cell
signaling, cellular assembly, cell morphology, and gene expression regulations were denoted by IPA.
Conclusions: These results characterized ID related cross-region interrelations and multiple networks of candidate
BEGs from the detected genomic imbalances. Further experimental study of these BEGs and their interactions will
lead to a better understanding of dosage-sensitive mechanisms and modifying effects of human mental
development.
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Intellectual disability (ID), also known as mental retard-
ation, is characterized by significant limitations in intellec-
tual functioning and adaptive behavior and is frequently
associated with developmental delay (DD) and multiple
congenital anomalies (MCA) [1]. Conventional cytogen-
etic evaluation of ID/DD/MCA showed an abnormality
detection rate of 3.7% by karyotyping for large numerical
and structural chromosomal abnormalities and up to 6.8%
when combined with fluorescence in situ hybridization
(FISH) analysis for targeted cryptic and subtelemeric rear-
rangements [2]. However, this molecular cytogenetic ana-
lysis was limited by the average Giemsa banding resolution
of 5–10 megabase (Mb) and the number of targeted probes
available in FISH analysis. For the past five years, genomic
technologies using oligonucleotide array comparative
genomic hybridization (aCGH) or a single nucleotide
polymorphism (SNP) chip have been validated and rec-
ommended as first-tier genetic testing in replacing the
conventional cytogenetic analysis [3,4]. Integration of
genomic analysis into clinical cytogenetic services has
filled the gap between the megabase-range G-band and
the kilo-base level gene and proven to be highly effective
in defining the genomic localizations and gene contents
from recurrent genomic disorders, interstitial imbalances
and subtelomeric rearrangements. The clinical application
of aCGH for large case series of children and newborns
has been reported; the diagnostic yield from cytogenomic
analysis on pediatric patients with ID/DD/MCA and aut-
ism is about 12-20% [5-13].
It has been hypothesized that the general ID/DD
phenotype from chromosomal segmental imbalances and
genomic copy number variants (CNVs) is caused by dosage-
sensitive mechanisms of involved genes. A chromosomal
map which associated human brain congenital malfor-
mations with specific chromosomal regions had been
constructed, but this low resolution map is of limited
value for identifying dosage-sensitive genes [14]. Current
cytogenomic analysis has facilitated accurate subtractive
mapping of critical regions or intervals for identifying
candidate genes in an increasing number of patients. For
example, the breakpoints and gene content mediated by
regional low copy number repeats (LCRs) of 15q12 for
Prader-Willi or Angelman syndrome and of 22q11.2 for
DiGeorge syndrome have been defined [15,16]. However,
the lack of commonly accepted protocols for CNV prio-
ritization and data concerning the gene dosage effect in
the human genome makes it difficult to identify the
disease-causing genes. To date it is still a technical chal-
lenge to predict candidate dosage-sensitive genes from the
detected chromosomal and genomic abnormalities.
In the post-Genome era, many bioinformatic tools
have been developed for biological interpretation of large
gene lists derived from high-throughput experiments.Gene annotation enrichment analysis is one of the
widely used approaches to statistically determine the
most over-represented gene ontology (GO) terms and
reveal the underlying biological processes in a group of
genes [17]. Another strategy is to look for functionally
related or interacting genes across genetic loci [18].
More recently, Gene Relationships Across Implicated
Loci (GRAIL) has been applied to dissect common bio-
logical pathways affecting various phenotypes from SNP
variants across genomic loci [19-21]. Similarly, Ingenuity
Pathway Analysis (IPA), a web-delivered application, pro-
vides an integrated knowledge base comprising over
200,000 full text articles about the human genome and en-
ables discovery and exploration of molecular interaction
networks. It has been used to assess the functional bio-
logical networks and the candidate genes from the recur-
rent 16p11.2 microdeletions and the 1p34 microdeletion
associated with autism [22,23].
In this study we used integrated cytogenomic mapping
and bioinformatic mining to identify potential candidate
genes and common gene interactions or networks from
176 genomic imbalances detected by aCGH from 1354
individuals with ID/DD/MCA and autism. Gene ontol-
ogy enrichment of brain-expressed genes (BEGs) was
noted by the gene functional classification analysis tool,
Database for Annotation, Visualization, and Integrated
Discovery (DAVID). Further gene-interaction analysis
using GRAIL identified 108 candidate genes with related
biological functions and strong interrelation cross imbal-
ance regions. Pathway analysis using IPA denoted five
significant gene networks involving cell cycle, cell-to-cell
signaling, cellular assembly, cell morphology, and gene
expression regulations. These findings provide insight into
the cross-region interrelations of the BEGs and possibly
the underlying dosage-sensitive mechanisms and modify-
ing effects for human mental development.
Results
CNV characterization and classification
Of the 1354 pediatric patients referred for oligonucleotide
aCGH analysis, 373 genomic imbalances were detected;
205 of these imbalances were denoted as pathogenic ab-
normalities in 176 patients (an individual may have more
than one imbalance) and 168 imbalances were classified
as VOUS (data not shown). The abnormality detection
rate was 13.0% (176/1354). Excluding cases with simple
aneuploidies, the 190 genomic abnormalities showed a
mean genomic size of 6.6 Mb and a mean gene content of
47 genes per imbalance. The diagnosis yield of 14.0% by
the 180 K microarray was slightly higher than the 12.5%
by 44 K microarray. Approximately 60% of the genomic
imbalances were deletions and 40% were duplications.
Abnormalities detected at the terminal 10–15 Mb in large
autosomes numbered 1 to 12 and terminal 5–10 Mb in
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ered to be subtelomeric rearrangements. Abnormalities
found between centromere and subtelomeric, excluding
the recurrent genomic disorders, are considered to be
interstitial imbalances.
The workflow of cytogenomic mapping and bioinfo-
matic mining is outlined in Figure 1. Details of the
aCGH results are summarized in Additional file 1: Table S1,
Additional file 2: Table S2, Additional file 3: Table S3,
Additional file 4: Table S4. The detected abnormalities
were classified into five categories: recurrent genomic dis-
orders mediated by regional low-copy repeats in 66 cases
(37.5%, 66/176) (Additional file 1: Table S1), subtelomeric
abnormalities resulting from terminal deletions or unbal-
anced rearrangements in 45 cases (25.6%) (Additional file 2:
Table S2), sporadic interstitial deletions and duplications in
33 cases (18.8%) (Additional file 3: Table S3), chromosomal
structure abnormalities in 17 cases (9.7%) (Additional file 4:
Table S4) and simple aneuploidies in 15 cases (8.5%). A
genome-wide view of the detected genomic disorders,
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Figure 1 Flowchart for abnormality classification and bioinformatic fichromosomal structural abnormalities is shown in Figure 2.
The most frequently detected genomic disorders were de-
letions of the 22q11.21 in 13 cases (OMIM188400) and
the reciprocal duplication (OMIM 608363) in three cases.
The subtelomeric rearrangements included simple ter-
minal deletions and duplications identified in 31 cases and
de novo or familial subtelomeric rearrangements in 14
cases. The size distribution of deletions and duplications
from genomic disorders, subtelomeric and interstitial rear-
rangements is shown in Figure 3. The average size of dele-
tions for subtelomeric and interstitial rearrangements was
4.9 Mb and 6.0 Mb while the average size of duplications
was 5.2 Mb and 6.4 Mb, respectively. The 15 cases of
simple aneuploidies included seven cases of trisomy 21,
one trisomy 13 and seven cases of sex chromosome
aneuploidies.
Functional annotation enrichment
Excluding the 15 cases with simple aneuploidies, cytoge-
nomic mapping was performed on the remaining 161
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Figure 2 A genome-wide view of detected abnormalities. Detected recurrent genomic disorders, subtelomeric rearrangements, interstitial
imbalances, and structural chromosomal abnormalities are shown in its category with genomic location and relative frequency (downward red
bar for deletion and upward blue bar for duplication).
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disjointed critical regions belonging to recurrent genomic
disorders, subtelomeric and interstitial regions were de-
fined; a total of 4080 genes were retrieved from the
UCSC RefGene table (Additional file 5: Table S5). Func-
tional annotation tool DAVID was used to analyze each
gene list from recurrent genomic disorders, subtelo-
meric rearrangements, interstitial imbalances and structuralGenomic disorders Subtel Abns Interstitial Abns
Figure 3 The size distribution of genomic disorders,
subtelomeric rearrangements and interstitial imbalances. The
average sizes for deletions and duplications are 2.2 Mb and 1.4 Mb
for genomic disorders, 4.9 Mb and 5.2 Mb for subtelomeric
abnormalities (abns), and 6.0 Mb and 6.2 Mb interstitial
abnormalities, respectively.chromosomal abnormalities with gene tissue expression
annotations derived from uniprot (UP_TISSUE). Gene
lists in the genomic disorder, subtelomeric and interstitial
critical regions were noted to be enriched for brain spe-
cific genes (p < 0.05). To avoid biased tissue information
from Uniprot and to understand the expression pattern
comprehensively, the tissue expression enrichment was
further investigated using GNF_U133A, a world-class tis-
sue expression database. The results showed that genes in
these four lists are all enriched in central nervous systems
(CNS) (Additional file 6: Figure S1). Genes in recurrent
genomic disorders and subtelomeric regions are preferen-
tially expressed in medulla oblongata (p < 0.005), hypo-
thalamus (p < 0.05) and pituitary (p < 0.1), while genes in
interstitial and structural abnormal regions are enriched
in cingulate cortex (p < 0.05), cerebellum (p < 0.1) and oc-
cipital lobe (p < 0.1). The enrichments were confirmed by
1000 runs of permutation. This observation indicated that
there is brain functional gene enrichment in the defined
critical regions.
Relationship between the numbers of the BEGs and the
size of the abnormal loci
Based on findings that genes preferentially expressed in
variable sites of the CNS are enriched in the critical re-
gions, candidate BEGs were sorted out using the method
described by Raychaudhuri, which examined and com-
pared gene expression pattern in different tissues with
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with p < 0.01 were identified as preferentially expressed in
the CNS system. A total of 461 BEGs from 73 disjointed
critical regions in 133 cases were defined (Additional file 7:
Table S6). In nine disjointed critical regions, there were no
BEGs using this approach.
To evaluate the distribution of the number of BEGs in
the critical regions and test whether the number of BEGs
was over-represented in comparison to random loci with
the same number of genes, permutation-based empirical
distributions were conducted for the 16 regions in
recurrent genomic disorders, 39 disjointed regions inFigure 4 Boxplots showing the permutation-based empirical distribut
different gene content sizes (measured by gene numbers). For each o
loci with gene content size defined by the same number of genes as the t
number of genes located in each regions, and the Y-axis stands for the nu
abnormal region was shown as big solid red square.subtelomeric rearrangements, 34 disjointed regions in
interstitial imbalances and 17 disjointed regions in
structural abnormalities. For each abnormal region, the
number of BEGs in the random loci was determined
and compared with that of the abnormal regions by
boxplot. Although variations were noted in some recur-
rent genomic disorder regions, the overall distribution
showed that the number of BEGs in detected abnormal
regions is positively correlated to the size of the region
(Figure 4). This observation indicated that the number
of BEGs likely increases with the size of gene content of
the imbalance regions.ions of the number of BEGs observed in the critical regions of
f the 82 targeted abnormal regions, a set of 10,000 random genomic
arget regions was drawn from the genome. The X-axis represents the
mbers of BEGs observed. The actual numbers of BEGs detected in each
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interaction
To test the hypothesis that there may be functional inter-
relations of the BEGs across critical regions and identify
possible candidate genes, a statistical method GRAIL was
applied to assess the degree of relatedness of the listed
461 BEGs [21]. A text-based similarity metric derived
from PubMed literature was used to assess the relatedness
between genes across the 73 regions. A subset of 108
genes were implicated inter-connection (ptext < 0.01)
(Table 1), and the words that strongly linked the signifi-
cant genes in each region were defined as keywords.
The top keywords are ‘neuron’, ‘brain’, ‘synaptic’ ‘gaba’
and ‘kinase’, which indicate the common biological func-
tions of these genes. In addition to PubMed literature,
other two gene relatedness metrics – Gene Ontology
(GO) annotations and gene expression patterns across
multiple human tissues were also used. A total of 45
genes obtained pannotation < 0.01 with GO similarityTable 1 List of candidate genes identified by GRAIL
G-band Candidate gene G-band Candidate gene
1p36.3 PRKCZ 5q35.2 CLTB
1p36.3 GABRD 5q35.3 MAPK9
1q43-q44 AKT3 6q24.1q25.3 AKAP12
2p21 NRXN1 6q26q27 PDE10A 12
2q22.2q23.3B KIF5C 6q26q27 RPS6KA2 12
2q24.3q31.1 STK39 7p22.2 PRKAR1B 12
2q24.3q31.1 GAD1 7q21.3 DYNC1I1 1
2q24.3q31.1 RAPGEF4 7q22.1q31.3 NRCAM 1
2q24.3q31.1 SCN1A 7q35 CNTNAP2 1
3p26.2p22.1 DYNC1LI1 7q36.2 DPP6 1
3p26.2p22.1 MOBP 8p23.3-p11.21 NEFL 1
3p26.2p22.1 ATP2B2 8p23.3-p11.21 NEFM 1
3p26.2p22.1 SYN2 8p23.3-p11.21 NRG1 1
3p26.2p22.1 SLC6A1 8p23.3-p11.21 STMN4
3q21.3q22.3 PIK3CB 8p23.3-p11.21 DPYSL2
3q27.1q29 CAMK2N2 8p23.3-p11.21 PTK2B
3q27.1q29 SST 8q24.12-q24.3 PTK2
3q28-qter APOD 9p24.3-p12 SLC1A1
4p16.3p16.1 CRMP1 9p24.3-p12 DCTN3
4p16.3p16.1 WFS1 9p24.3-p12 CLTA
4p16.3p16.2 HTT 9p24.3-p12 PTPRD
4q34.1-34.3 GPM6A 9p24.3-p12 UNC13B
4q34.1-34.3 SCRG1 9q22.32-q21.2 GABBR2 1
5p14.1p12 SLC1A3 10q26.12-26.3 DPYSL4
5p15.33p14.1 MYO10 11q23.3q25 SORL1 1
5p15.33p14.1 BASP1 11q23.3q25 SCN3B
5q35.2 SNCB 11q23.3q25 FEZ1and a subset of 317 genes achieved pexpression < 0.01
with expression similarity. The results from these three
data sources showed that 27 genes were common to all
three functional data sources and 74 genes were shared
in two functional data sources (Additional file 6: Figure S2).
Interestingly, among these candidate genes, CRMP1,
PAFAH1B1 and PDE4D are spindle related genes, imply-
ing that the proper centrosome function is critical for
brain development. The top five terms which show strong
functional enrichments were neurological process, trans-
mission of nerve pulse, synaptic transmission, cell junction
and central nervous system neuron axonogenesis (p < 0.001).
The functional connections among implicated genes in
the 73 regions were shown in Figure 5 and Additional file 6:
Figures S3 and S4.
Gene network and pathway analysis
To understand the potential functional interactions of the
461 BEGs, Ingenuity Pathway Analysis (IPA) was performedG-band Candidate gene G-band Candidate gene
11q23.3q25 HNT 17p13.2 ATP1B2
11q23.3q25 NRGN 17p13.2 EFNB3
11q23.3q25 JAM3 17p13.3 PAFAH1B1
p13.33p11.1 KRAS 18q22.1-q23 CBLN2
p13.33p11.1 PTPRO 18q22.1-q23 MBP
p13.33p11.1 ENO2 20p13-q11.23 DYNLRB1
3q11.1qter DCLK1 20p13-q11.23 PTPRA
3q11.1qter MYCBP2 20p13-q11.23 EPB41L1
3q11.1qter ITM2B 20p13-q11.23 SNTA1
3q11.1qter RAP2A 20p13-q11.23 CHGB
3q11.1qter SACS 20p13-q11.23 PAK7
3q11.1qter SLITRK5 20p13-q11.23 SNPH
3q11.1qter CLDN10 20p13-q11.23 ATRN
15q11-13 APBA2 20p13-q11.23 PRNP
15q11-13 TJP1 20p13-q11.23 SNAP25
15q11-13 GABRA5 21q22.3 S100B
15q24 CPLX3 22q11.2 CLDN5
15q24 NPTN 22q11.2 SEPT5
15q24q26.3 SV2B 22q13.31-q13.33 MLC1
15q24q26.3 NTRK3 Xq21.2q28 L1CAM
15q24q26.3 CHRNA3 Xq21.2q28 PAK3
15q24q26.3 HDGFRP3 Xq21.2q28 DCX
6p12.2-p11.2 PRKCB1 Xq21.2q28 ATP6AP1
16p13.3 METRN Xq21.2q28 PCDH19
6q22.1-22.3 CALB2 Xq21.2q28 PLXNB3
17p13.2 DLG4 Xq21.2q28 FMR1
17p13.2 NDEL1 Xq21.2q28 PLP1
Figure 5 Functional connections between genes at the 73 critical regions inferred by GRAIL. The double circle plots depict the gene
relationships across the abnormal regions by GRAIL based on data source PubMed Text. Outer circle represents abnormal regions, of which the
G-band regions with '_del' are denoted deletions and the other regions are duplications. The inner circle stands for genes located in the corresponding
regions in the outer circle, and for clear visualization only significant genes (p < 0.001) and their connections are shown. The lines represent pair-wise
gene connections, with the thickness of the lines indicating the degree functional similarity.
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biological process. The highest rated network of genes
identified by IPA contains 31 significant genes which
function in cell cycle, cell-to-cell signaling and interaction,
nervous system development and function (Figure 6). In
this network, eight genes including PRKAR1B, DLG4,
NRCAM, GABRD, BCR, AMOTL2, ENO2, C16orf45 were
also derived from GRAIL analysis. As shown in Figure 6,DLG4, the hub gene in network 1, interacts with 12 genes
and has the highest degree (degree = 12, defined as the
number of linked genes). IPA also denoted the other top
four gene networks related to cellular assembly and
organization, cellular function and maintenance and cell
morphology. Three of them enriched for genes involved in
nervous system development and function (Additional file 6:
Figures S5-S8).
Figure 6 The primary functional network of BEGs identified by the ingenuity pathway analysis. Nodes represent genes and a solid line
means a direct interaction between the two genes and a dotted line stands for an indirect relationship. Shaded nodes represent genes within
the abnormal regions (genes denoted with underlined G-band position are in the candidate gene list of Table 1)
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Recently, genomic analysis using array-based CGH or
SNP chip was recommended as the first-tier genetic test
for individuals with ID/DD/MCA and autism because of
its high sensitivity and specificity for detecting submicro-
scopic deletions and duplications [3]. In this study, of the
1354 individuals with ID/DD/MCA/autism analyzed using
Agilent’s 44 K and 180 K oligonucleotide arrays, 176 pa-
tients (13.0%) were detected with pCNVs, chromosomal
structural abnormalities and aneuploidies. This diagnostic
yield is in consistent with the reported range of 12%-20%
by several studies [5-13,24-26]. Of all the abnormal cases,
the largest proportion (37.5%) belongs to recurrent gen-
omic disorders and the other two significant groups are
subtelomeric rearrangements (25.6%) and sporadic inter-
stitial abnormalities (18.8%). Recurrent genomic disorders
are well recognized to be responsible for syndromic phe-
notypes. Recently, two case–control studies with large
case series further define the phenotypes of recurrent gen-
omic disorders and suggested further effort to develop a
genome-wide map for dosage sensitive genes [9,24]. Sub-
telomeric and interstitial abnormalities showed larger vari-
ations in their size distribution and associated phenotypes.
Therefore, it will be more difficult to identify the disease-
causing genes.Cytogenomic mapping of disjointed critical regions
from the detected genomic imbalances allowed further
bioinformatic mining for potential disease-causing genes.
Of the 4080 genes sorted from the defined critical re-
gions, about 11.3% (461/4080) of the genes showed brain
specific expression by bioinformatic mining. Although
the number of BEGs increases with the gene content of
genomic regions, the enrichment of genes preferentially
expressed in CNS tissues was noted by the gene annota-
tion analysis. This observation suggested that the func-
tional interactions rather than the number of the BEGs
are more likely related to the ID phenotype. From the
461 BEGs, a subset of genes was identified with high re-
latedness through a statistical text mining approach.
This enables us to recognize the biological connections
across the disease-causing regions. In this subset of
highly related genes, five genes have been established as
causative genes for well-known mental retardation syn-
dromes. These are GABRD for 1p36 deletion and dupli-
cation syndrome, NPTN for 15q24 BP0-BP1 deletion
syndrome, PAFAH1B1 for 17p13.3 deletion and duplica-
tion syndrome, MECP2 for Rett syndrome, and FMR1
for fragile X syndrome. The identification of the known
causative genes for ID/DD demonstrated the validity of
this data mining approach.
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disorders. Recent evidence indicated that defects in syn-
aptogenesis and synaptic activities and deregulation of
neuronal development and function may contribute to
pathogenesis of ID/DD [1]. Many of the candidate genes
recovered by GRAIL are involved in neurological system
process, synaptic transmission, cell junction and neuron
axonogenesis. Part of the cross-loci interactions of gene
ontology from detected deletions and duplications have
been presented previously [27]. For example, the DLG4
gene, a member of synaptic molecules, is a major func-
tional bridge in coupling the N-methyl-D-aspartate re-
ceptor to pathways that control bidirectional synaptic
plasticity and learning. The phenotypes of DLG4 knockout
mouse have been related to nervous system abnormalities
[28]. The NRXN1 gene which interacts with its postsynap-
tic binding partner at the synapse has been associated with
neurological diseases [29,30]. It is also noted that some of
the BEGs did not show significant p-values (e.g, STS gene
in Xp22.3 has a p-value of 0.83 when text is used). Actu-
ally, this exploratory bioinformatic mining was performed
on a set of 4,080 genes, about one fifth of the estimated
over 20,000 human genes. The inclusion of more abnor-
mal cases and an increase in gene coverage will lead to
more comprehensive mining of functional interactions
and networks of candidate genes.
The pathway analyses by IPA also found that the BEGs
are enriched in neurological disease and endocrine system
disorders. The DLG4, FMR1, FXR2 and YWHAE genes
with at least four neighbors (degree > = 4) in Network 1
are all related to neural disorders. The DLG4 gene is a
homologue of a known disease-causing gene DLG1. The
FMR1, FXR2 and YWHAE genes have been reported in ID
related studies. Moreover, SNRPN, one of the deleted
genes for Prader-Willi syndrome, is also directly con-
nected to the DLG4 gene. This network of genes showed
strong functional homogeneity and should be considered
a significant network underlying the ID/DD mechanism.
Network 2 can be approximately divided into four sub
networks connected by the S100B gene which is related to
neurodegeneration. One of the sub networks involved in
cellular assembly and organization included spindle re-
lated genes such as CRMP1, indicating the important role
of centrosome genes in neuron development. Another in-
teresting finding is the detection of significant enrichment
in the extracellular signal-regulated kinases (ERK) and
mitogen-activated protein kinase (MAPK) signaling path-
way by IPA. It has been demonstrated that ERK/MAPK is
involved in human genomic disorders [31]. A previous
bioinformatic analysis on a small case series showed gene
prioritization within MAPK and neuroactive ligand-
receptor interaction pathways [26]. A study on 1275 aut-
ism cases discovered an enrichment of CNVs disrupting
functional gene sets involved in cellular proliferation,projection and motility and GTPase/Ras signaling [32].
Our study identified many significant genes and function
pathways overlapped with those previous studies. Further
experimental analysis to connect the functional genomics
and molecular pathways is required for a better under-
standing of human brain and nervous system develop-
ment [33].
Conclusions
In summary, we performed oligonucleotide aCGH to iden-
tify a spectrum of cytogenomic abnormalities including
genomic disorders, subtelomeric rearrangements, intersti-
tial imbalances, and chromosomal structural and numer-
ical abnormalities. Further cytogenomic mapping and
bioinformatic mining identified a set of candidate BEGs
and reveal the underlying functional interrelations and net-
works likely contributing to the ID/DD phenotypes. The
identification of cross-region interrelations of the BEGS
could provide clues of related ID phenotypes and possible
modifying effect for phenotype variations for better disease
classification. The finding of five major networks suggested
complex polygenic and multipathway models underlying
haploinsufficiency and triple-sensitive regulation of mental
development. However, this bioinformatic mining cannot
differentiate the driving genetic factors from the modifying
effects for the ID phenotypes. Further experimental ana-
lysis on animal or cellular models to characterize this com-
plex genetic regulation is needed.
Methods
Subjects
The Yale Laboratory of Molecular Cytogenetics and
Genomics is CLIA-approved and provides diagnostic
services for pediatric patients with indications of ID,
DD, MCA, learning disability, speech delay and autism.
From 2006 to 2011, aCGH analyses were performed on
1354 pediatric patients using two array platforms: Agi-
lent 44 K oligonucleotide array on 718 patients and Agi-
lent 180 K oligonucleotide array on 636 patients. For
cytogenomic mapping and bioinformatic mining of po-
tential candidate genes from the abnormal findings, all
patient information had been de-identified. There were
no additional pre-study requirements on the patient's
specimen and clinical indications and there were no
post-study interaction and intervention with the patients.
This project was categorized as a chart review retrospect-
ive study and deemed exemption from Institutional Re-
view Boards (IRB) approval and waiver of consent based
on the policy of Yale University IRB.
Oligonucleotide array comparative genomic hybridization
(aCGH)
Genomic DNA was extracted from peripheral blood lympho-
cytes using the Gentra Puregene Kit (Qiagen, Valencia, CA).
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Drop spectrophotometer (Thermo Fisher Scientific, Inc.,
Waltham, MA) and high molecular weight DNA was veri-
fied by agarose gel electrophoresis. For each sample, 2–3
ug of genomic DNA was used following the manufac-
turer’s protocol for the Agilent Human Genome CGH
microarray 44 K kit (containing 44,913 60-mer oligonucle-
otides) and 180 K kit (177,873 60-mer oligonucleotides)
(Agilent Technologies, Inc., Santa Clara, CA). This aCGH
procedure can achieve 99% sensitivity and 99% specificity
using a sliding window of five to seven contiguous oligo-
nucleotides, indicating an analytical resolution of 300–500
kilobase (Kb) for the 44 K platform and 100–150 Kb for
the 180 K platform [4]. The base pair designations of 44 K
and 180 K aCGH were based on the May 2004 Assembly
(NCBI35/hg17) and the March 2006 Assembly (NCBI36/
hg18) of the UCSC Human Genome browser (http://gen-
ome.ucsc.edu/), respectively.
The genomic imbalances detected by aCGH were classi-
fied as (1) chromosome abnormalities, (2) pathogenic CNV
(pCNV), (3) variant of uncertain clinical significance
(VOUS) and (4) benign CNV (bCNV) [34]. As previously
described, large chromosome abnormalities (>5 Mb) were
confirmed by high resolution karyotyping on metaphases
prepared from cultured peripheral blood lymphocytes
using the laboratory’s standardized protocols; small imbal-
ances were confirmed by FISH using available commercial
probes or targeted BAC probes [4]. Raw data of all de-
tected chromosomal imbalances were loaded onto the
Nexus5 Software (BioDiscovery, Los Angles, California,
USA) to evaluate the genome-wide distribution and relative
frequency of chromosomal and genomic abnormalities.
Fluorescence in situ hybridization (FISH)
To confirm the subtelomeric chromosome rearrangements
and common genomic disorders detected by aCGH, FISH
using selected ToTelVysion probes and locus-specific
probes (Vysis/Abbott, Abbott Park, IL) as well as home
brew targeted BAC probes was performed as previously
described [4].
Cytogenomic mapping and bioinformatic analysis
A two-step cytogenomic mapping procedure was used
to define critical regions from detected genomic abnor-
malities. First, segments overlapping with known bCNVs
that have been documented at least three times in the
Databases of Genomic Variants (DGV) within a pCNV
were subtracted. Secondly, pCNVs were compared with
other overlapping pCNVs associated with ID/DD from
DECIPHER, and the smallest overlapped regions were
extracted as critical regions. The gene content within
each critical region was obtained based on gene coordin-
ate (hg18) from the UCSC database browser [35]. Subse-
quent data mining focused on the BEGs from definedcritical regions assuming that their functional interac-
tions and networks likely contribute to human mental
development.
Gene functional classification analysis
The tissue expression analysis was performed using the
DAVID Gene Functional Classification Tool with the
‘GNF_U133A_QUARTILE’ option [36]. DAVID would
report the tissues in which the gene expresses higher
than 3rd quartile of its expression across all tissues. More-
over, the tissue expression patterns were further con-
firmed by 1,000 runs of permutation tests. For each run, a
set of random genes with the same number of genes as
that in the critical regions was generated and the number
of genes expressed in a specific tissue was recorded.
Identification and distribution of brain-expressed genes
(BEGs)
A list of BEGs was obtained following the procedures of
Raychaudhuri et al. (2009a) [18]. Briefly, a widely used
large human normal tissue expression dataset (Human
U133A/GNF1H Gene Atlas) [37] was downloaded from
the BioGPS website (http://www.biogps.org/) [38]. The
downloaded expression data were gcRMA-normalized
and averaged across replicates. Genes with expression
values < 100 across all the tissues were excluded, since
they are considered not expressed. One-tailed Mann–
Whitney rank-sum p-values were then obtained to deter-
mine whether the genes express higher in the brain or
spinal cord (21 tissues) than in the remaining tissue pro-
files. Genes with p < 0.01 were considered as BEGs.
For every defined critical region, a set of 10,000 random
genomic loci was produced, each of which comprised of
the same number of genes as in the tested critical region,
and permutation of the random gene sets was conducted.
For a specific region R, 10,000 consecutive regions of N
genes (where N is the number of genes in R) were sampled
from the set of the genes profiled on Human U133A/
GNF1H platforms. The number of BEGs in the random
gene set was recorded and then compared with that in
true abnormal region R by boxplots.
Identification of candidate genes by gene interaction and
networking
To examine the interrelations among the listed BEGs
from different critical regions, GRAIL was used to as-
sess the functional similarities by using PubMed ab-
stracts, gene ontology terms or expression patterns in
normal human tissues [18]. All critical regions contain-
ing BEGs were submitted as both seed and query re-
gions and gene relationships among the abnormal
regions were visualized by tools provided on the website
(http://www.broadinstitute.org/mpg/grail/ ). The listed
BEGs were also imported into the IPA software (Ingenuity
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actions between the focus genes and other gene objects.
Web resources
Database of Genomic Variants (DGV): http://projects.tcag.
ca/variation/.
DatabasE of Chromosomal Imbalance and Phenotype
in Humans using Ensembl Resources (DECIPHER):
http://decipher.sanger.ac.uk/.
BioGPS website (http://www.biogps.org/).
Gene Relationships Across Implicated Loci (http://www.
broadinstitute.org/mpg/grail/.
Ingenuity Pathways Analysis (Ingenuity Systems Inc.,
RedwoodCity, California, USA; http://www.ingenuity.com/).
Additional files
Additional file 1: Table S1. Detected recurrent genomic disorders.
Additional file 2: Table S2. Subtelomeric chromosomal and genomic
rearrangements.
Additional file 3: Table S3. Sporadic interstitial chromosomal and
genomic imbalances.
Additional file 4: Table S4. Chromosome structural abnormalities.
Additional file 5: Table S5. Disjointed critical regions defined by
cytogenomic mapping.
Additional file 6: Figure S1. The distribution for the number of genes
in a specific tissue. Arrow points to number of genes from abnormal
regions. Figure S2. The number of candidate genes overlapping
between the three data sources. Figure S3. Functional connections
between genes at the 73 critical regions inferred by GRAIL based on
Gene Ontology (significant genes with p < 0.01). Figure S4. Functional
connections between genes at the 73 critical regions inferred by GRAIL
based Human Expression Alta (significant genes with p < 0.0000000001).
Figure S5. The secondary functional network of BEGs identified by the
Ingenuity pathway analysis (genes denoted with red colored G-band
position are in the candidate gene list of Table 1). Figure S6. The third
functional network of BEGs identified by the Ingenuity pathway analysis
(genes denoted with red colored G-band position are in the candidate
gene list of Table 1). Figure S7. The fourth functional network of BEGs
identified by the Ingenuity pathway analysis (genes denoted with red colored
G-band position are in the candidate gene list of Table 1). Figure S8. The
fifth functional network of BEGs identified by the Ingenuity pathway analysis
(genes denoted with underlined G-band position are in the candidate gene
list of Table 1).
Additional file 7: Table S6. List of brain expressed genes.
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